These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16498067)
1. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. Chen PN; Hsieh YS; Chiang CL; Chiou HL; Yang SF; Chu SC J Dent Res; 2006 Mar; 85(3):220-5. PubMed ID: 16498067 [TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chen PN; Hsieh YS; Chiou HL; Chu SC Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542 [TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel. Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189 [TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Chu SC; Chiou HL; Chen PN; Yang SF; Hsieh YS Mol Carcinog; 2004 Jul; 40(3):143-9. PubMed ID: 15224346 [TBL] [Abstract][Full Text] [Related]
5. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Yang SF; Yang WE; Kuo WH; Chang HR; Chu SC; Hsieh YS Arch Oral Biol; 2008 Mar; 53(3):287-94. PubMed ID: 17936716 [TBL] [Abstract][Full Text] [Related]
6. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9. Ho YT; Yang JS; Li TC; Lin JJ; Lin JG; Lai KC; Ma CY; Wood WG; Chung JG Cancer Lett; 2009 Jul; 279(2):155-62. PubMed ID: 19251361 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway. Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024 [TBL] [Abstract][Full Text] [Related]
8. Alpha-carotene inhibits metastasis in Lewis lung carcinoma in vitro, and suppresses lung metastasis and tumor growth in combination with taxol in tumor xenografted C57BL/6 mice. Liu YZ; Yang CM; Chen JY; Liao JW; Hu ML J Nutr Biochem; 2015 Jun; 26(6):607-15. PubMed ID: 25736483 [TBL] [Abstract][Full Text] [Related]
9. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. Lai KC; Huang AC; Hsu SC; Kuo CL; Yang JS; Wu SH; Chung JG J Agric Food Chem; 2010 Mar; 58(5):2935-42. PubMed ID: 20136087 [TBL] [Abstract][Full Text] [Related]
10. Flavanone and 2'-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Hsiao YC; Kuo WH; Chen PN; Chang HR; Lin TH; Yang WE; Hsieh YS; Chu SC Chem Biol Interact; 2007 May; 167(3):193-206. PubMed ID: 17376416 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Peng PL; Hsieh YS; Wang CJ; Hsu JL; Chou FP Toxicol Appl Pharmacol; 2006 Jul; 214(1):8-15. PubMed ID: 16387334 [TBL] [Abstract][Full Text] [Related]
12. Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo. Yang SF; Chu SC; Liu SJ; Chen YC; Chang YZ; Hsieh YS J Ethnopharmacol; 2007 Apr; 110(3):483-9. PubMed ID: 17113737 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis. Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352 [TBL] [Abstract][Full Text] [Related]
14. Antimetastatic potentials of salvianolic acid A on oral squamous cell carcinoma by targeting MMP-2 and the c-Raf/MEK/ERK pathway. Fang CY; Wu CZ; Chen PN; Chang YC; Chuang CY; Lai CT; Yang SF; Tsai LL Environ Toxicol; 2018 May; 33(5):545-554. PubMed ID: 29385302 [TBL] [Abstract][Full Text] [Related]
15. Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells. Kim S; Kim SH; Hur SM; Lee SK; Kim WW; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH J Ethnopharmacol; 2009 Nov; 126(2):252-7. PubMed ID: 19715751 [TBL] [Abstract][Full Text] [Related]
16. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9. Chen YY; Chiang SY; Lin JG; Ma YS; Liao CL; Weng SW; Lai TY; Chung JG Int J Oncol; 2010 May; 36(5):1113-20. PubMed ID: 20372784 [TBL] [Abstract][Full Text] [Related]
17. Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2. Hsieh YS; Chu SC; Yang SF; Chen PN; Liu YC; Lu KH Carcinogenesis; 2007 May; 28(5):977-87. PubMed ID: 17116726 [TBL] [Abstract][Full Text] [Related]
18. Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway. Ho ML; Chen PN; Chu SC; Kuo DY; Kuo WH; Chen JY; Hsieh YS Nutr Cancer; 2010; 62(4):505-16. PubMed ID: 20432172 [TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Wu KJ; Zeng J; Zhu GD; Zhang LL; Zhang D; Li L; Fan JH; Wang XY; He DL Acta Pharmacol Sin; 2009 Aug; 30(8):1162-8. PubMed ID: 19578386 [TBL] [Abstract][Full Text] [Related]
20. Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways. Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lu PJ; Weng JR; Chueh FS; Wood WG; Chung JG Hum Exp Toxicol; 2011 May; 30(5):406-15. PubMed ID: 20511288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]